Sermorelin for Sale: 11.31 mg Behind a 10 mg Label

Read a listing field by field, because the fields commit the seller to wildly different things. Form, quantity, lot number and laboratory are checkable against a document. Adjectives are not, and the words that sell hardest are usually the ones with no document behind them.

Four of those rows are closed by a document. One is closed only by the vial in front of you, and one is not addressed at all. That last row is the one that matters most for a dry powder someone intends to put into solution, which is why it gets a section of its own below rather than a footnote.

A price divided by a label is an estimate. A price divided by an assay is a measurement. On this lot the two differ by more than 10 %, which is enough to reorder a comparison against another storefront.

The working is plain division. $36.00 ÷ 10 mg is $3.60. $36.00 ÷ 11.31 mg is $3.1830, which rounds to $3.18. The gap between the two columns is 11.6 % of the label rate, and it exists only because the lot was weighed rather than assumed.

State the limit of that figure as loudly as the figure itself. 11.31 mg is what one lot assayed on one date. It is not a specification, not a promise, and not something to build a purchase around if the vial you receive carries a different lot code. Treat the label mass as the number you paid for and the assayed mass as a property of lot 38-01260229 alone. Our sermorelin price breakdown runs the same division across quantity tiers and shipping.

99.79 % reads like a rounding error away from perfect, and in area terms it is. Converted to mass on this lot it stops being abstract.

The certificate reports 4 detected peaks with the main peak at 99.79 %. The remaining 0.21 % spread across the other three works out at 11.31 mg × 0.0021, or about 0.024 mg. That is roughly 24 micrograms of material the certificate detected and did not identify.

Run the same correction the other way and the vial still beats its label. 11.31 mg × 0.9979 is 11.29 mg of sermorelin, which is 12.9 % above the 10 mg the label commits to. On the discounted price that is $36.00 ÷ 11.29 mg, or $3.19 per milligram of assayed compound rather than $3.18 per milligram of total powder. The difference is a cent, and the point is not the cent. The point is that three defensible figures exist for the same vial, so anyone comparing storefronts has to say which one they used.

• $3.60/mg divides by the label. Comparable to any listing, because every listing has a label.
• $3.18/mg divides by the assay. Only comparable to another listing that publishes one.
• $3.19/mg divides by the purity-corrected assay. The most conservative of the three and the least often quoted.

The document covers purity and quantity. It carries no endotoxin test and no sterility test, and that scope belongs to this lot rather than to the product or the seller in general. A future lot may be tested more widely, and the only way to know is to read the certificate attached to it.

The gap matters because of what the material is. A lyophilised powder that someone puts into solution is a different risk profile from a tablet, and the concern regulators have expressed about this class of peptide is not primarily about the main peak. FDA's stated basis for placing several growth hormone secretagogues in its Category 2 bulk substances list is a risk for immunogenicity due to the potential for aggregation and peptide-related impurities. That is a statement about impurities and physical form, which is precisely the ground a purity-and-quantity certificate does not cover.

Sermorelin is absent from the Category 2 list, in every section, and the part of this page below explains why that absence is meaningful rather than an oversight. But a compound being left off a list does not answer a testing question. It only means the question was never escalated. Reading the certificate is still the work, and our source ranking weights testing scope above price for exactly this reason.

Most pages on this compound fail in one of two directions, and both failures are visible in the listing copy.

The first is treating it as a research chemical with no history. Sermorelin was marketed as Geref by EMD Serono under two approvals: NDA 019863 for diagnostic use, with submissions from 1991, and NDA 020443 for therapeutic use, approved on 1997-09-26. Both are now discontinued, and the FDA product record carries the Federal Register determination that the product was not discontinued or withdrawn for safety or effectiveness reasons. A listing that calls the compound banned or never approved is describing something else.

The second is the mirror image: present-tense approval language. There is no current US label. DailyMed returns no labelling for sermorelin at all, so any listing claiming an approved product is on the market today is wrong, and any that implies an approved adult indication is wrong twice. The approvals that existed covered paediatric growth hormone deficiency and pituitary diagnostics.

What the listing sells is therefore research material, and the honest description of the evidence behind the modern market is uncomfortable. PubMed returns 332 records mentioning sermorelin and 3 with it in the title. Search it alongside anti-aging and the count is zero. ClinicalTrials.gov registers no studies naming the compound. A listing that stays quiet about human benefit is not being coy, it is being accurate.

The number on the product page is not the number you spend, and two published rules move it.

Quantity tiers take 3 %, 5 % or 10 % off the list price, calculated separately from the code. Against a 50 % reduction from $72.00 to $36.00 those tiers are not close: 10 % off $99.99 is $89.99, which is $9.00 per labelled milligram, against $3.60 with the code. Whether a checkout lets the two combine is a cart rule, and the payment screen is the only place that settles it.

Free shipping starts at $250, and the code moves that line further away rather than closer. Seven vials at $36.00 total $252.00 and clear it. Three vials at the $99.99 list total $299.97 and clear it. Four at the $72.00 site price total $288.00 and clear it. Which subtotal the threshold reads is again a checkout rule rather than a published one.

Shipping itself is a fixed charge, so it divides by mass rather than scaling with it. Assume a flat $12.00, which the vendor does not publish and which is here only to show the shape of the effect: on a single 10 mg vial it adds $1.20 per labelled milligram, a third of the discounted vial price again, and across seven vials it would add $0.17 per milligram. Substitute whatever your cart actually charges. Fixed costs always fall hardest on the smallest order, which is why a cart total rather than a product price is the honest input to any comparison. If you want the storage side of the same decision, our peptide storage guide covers what a lyophilised vial needs before it is opened.